Multifocal Motor Neuropathy: A clinical case study

Australian Red Cross (2018) ‘Criteria for the clinical use of intravenous immunoglobulin in Australia’, Australian Red Cross, viewed 3 August 2018, https://transfusion.com.au/blood_products/fractionated_plasma/ivig.Australian Red Cross (2018) ‘Criteria for the clinical use of intravenous immunoglobulin in Australia’, Australian Red Cross, viewed 3 August 2018, https://transfusion.com.au/blood_products/fractionated_plasma/ivigSearch in Google Scholar

Berger, M., McCallus, D & Lin, C. (2013). ‘Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies’, Journal of the Peripheral Nervous System, Vol. 18, pp.275-296.BergerM.McCallusD & LinC. (2013). ‘Rapid and reversible responses to IVIG in autoimmune neuromuscular diseases suggest mechanisms of action involving competition with functionally important autoantibodies’, Journal of the Peripheral Nervous System, Vol. 18, pp.275-296.10.1111/jns5.12048428522124200120Search in Google Scholar

Cats, E., van der Pol, W., Piepers, S., Franssen, H., Jacobs, B., van den Berg-Vos, R., Kuks, J., van Doorn, P., van Engelen, B., Verschuuren, J., Wokke, J., Veldink, J & van den Berg, L. (2010). ‘Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy’, American Academy of Neurology, Vol. 75, pp.818-825.CatsE.van der PolW.PiepersS.FranssenH.JacobsB.van den Berg-VosR.KuksJ.van DoornP.van EngelenB.VerschuurenJ.WokkeJ.VeldinkJ & van den BergL. (2010). ‘Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy’, American Academy of Neurology, Vol. 75, pp.818-825.Search in Google Scholar

Dimachkie, M., Barohn, J & Katz, J. (2013). ‘Multifocal Motor Neuropathy, Multifocal Acquired Demyelinating Sensory and Motor Neuropathy and Other Chronic Acquired Demyelinating Polyneuropathy Variants’, Neurologic Clinics, Vol. 31, No. 2: pp.533–555.DimachkieM.BarohnJ & KatzJ. (2013). ‘Multifocal Motor Neuropathy, Multifocal Acquired Demyelinating Sensory and Motor Neuropathy and Other Chronic Acquired Demyelinating Polyneuropathy Variants’, Neurologic Clinics, Vol. 31, No. 2: pp.533–555.10.1016/j.ncl.2013.01.001409893723642723Search in Google Scholar

Hahn, A., Beydoun, S., Lawson, V., Oh, M., Empson, V., Leibl, H., Ngo, Y., Gelmont, D & Koski, C. (2013). ‘A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy’, Journal of peripheral nervous system, Vol. 18, No. 4: pp.321-330.HahnA.BeydounS.LawsonV.OhM.EmpsonV.LeiblH.NgoY.GelmontD & KoskiC. (2013). ‘A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy’, Journal of peripheral nervous system, Vol. 18, No. 4: pp.321-330.10.1111/jns5.1204624725024Search in Google Scholar

Jovanovich, E & Karam, C. (2015). ‘Human immune globulin infusion in the management of multifocal motor neuropathy’, Degenerative Neurological and Neuromuscular Disease, Vol. 2016, No. 6: pp.1-12.JovanovichE & KaramC. (2015). ‘Human immune globulin infusion in the management of multifocal motor neuropathy’, Degenerative Neurological and Neuromuscular Disease, Vol. 2016, No. 6: pp.1-12.10.2147/DNND.S96258605308430050363Search in Google Scholar

Katz, J., Lewis, R & Spatafora, D. (2017). ‘First Global Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey Identifies Needs in Education and Treatment’, Neurology, Vol.13, No. 16: pp. 1-15.KatzJ.LewisR & SpataforaD. (2017). ‘First Global Multifocal Motor Neuropathy (MMN) Quality of Life (QOL) Patient Survey Identifies Needs in Education and Treatment’, Neurology, Vol.13, No. 16: pp. 1-15.Search in Google Scholar

Latov, N. (2014). ‘Diagnosis and treatment of chronic acquired demyelinating polyneuropathies’, NEUROLOGY, Vol. 10, pp.435-442.LatovN. (2014). ‘Diagnosis and treatment of chronic acquired demyelinating polyneuropathies’, NEUROLOGY, Vol. 10, pp.435-442.Search in Google Scholar

Lawson, V & Arnold, W. (2014). ‘Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment’, Neuropsychiatric Disease and Treatment, Vol. 10, pp.567-576.LawsonV & ArnoldW. (2014). ‘Multifocal motor neuropathy: a review of pathogenesis, diagnosis, and treatment’, Neuropsychiatric Disease and Treatment, Vol. 10, pp.567-576.Search in Google Scholar

Léger, J., Guimarães-Costa, R & Iancu Ferfoglia, R. (2015). ‘The pathogenesis of multifocal motor neuropathy and an update on current management options’, Therapeutic Advances in Neurological Disorders, Vol. 8, No. 3: pp.109-122.LégerJ.Guimarães-CostaR & Iancu FerfogliaR. (2015). ‘The pathogenesis of multifocal motor neuropathy and an update on current management options’, Therapeutic Advances in Neurological Disorders, Vol. 8, No. 3: pp.109-122.10.1177/1756285615575269440954925941538Search in Google Scholar

Léger, J., Viala, K., Cancalon, F., Maisonobe, T., Gruwez, B., Waegemans, T & Bouche, P. (2008). ‘Intravenous immunoglobulin as short - and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients’, Journal of Neurology Neurosurgery Psychiatry, Vol. 79, pp.93-96.LégerJ.VialaK.CancalonF.MaisonobeT.GruwezB.WaegemansT & BoucheP. (2008). ‘Intravenous immunoglobulin as short - and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients’, Journal of Neurology Neurosurgery Psychiatry, Vol. 79, pp.93-96.10.1136/jnnp.2007.12175618079302Search in Google Scholar

Meuth, S & Kleinschnitz, C. (2010). ‘Multifocal Motor Neuropathy: Update on Clinical Characteristics, Pathophysiological Concepts and Therapeutic Options’, European Neurology, Vol. 63, pp.193-204.MeuthS & KleinschnitzC. (2010). ‘Multifocal Motor Neuropathy: Update on Clinical Characteristics, Pathophysiological Concepts and Therapeutic Options’, European Neurology, Vol. 63, pp.193-204.10.1159/00028273420150737Search in Google Scholar

Nobile-Orazio, E & Gallia, F. (2013). ‘Multifocal Motor Neuropathy: Current Therapies and Novel Strategies’, Drugs, Vol. 73, No. 5: pp.397-406.Nobile-OrazioE & GalliaF. (2013). ‘Multifocal Motor Neuropathy: Current Therapies and Novel Strategies’, Drugs, Vol. 73, No. 5: pp.397-406.10.1007/s40265-013-0029-z23516024Search in Google Scholar

Nowacek, D & Teener, J. (2012). ‘Multifocal Motor Neuropathy’, Seminars in Neurology, Vol. 32, pp.500-505.NowacekD & TeenerJ. (2012). ‘Multifocal Motor Neuropathy’, Seminars in Neurology, Vol. 32, pp.500-505.Search in Google Scholar

Schaika, I., Boucheb, P., Illac, I., Le´gerb, J., Van den Berghd, P., Cornblathe, D., Eversf, E., Haddeng, R., Hughesh, R., Koskii, C., Nobile-Orazioj, E., Pollardk, J., Sommerl, C & van Doorn, P. (2006). ‘European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy’, European Journal of Neurology, Vol. 13, pp.802-808.SchaikaI.BouchebP.IllacI.Le´gerbJ.Van den BerghdP.CornblatheD.EversfE.HaddengR.HugheshR.KoskiiC.Nobile-OraziojE.PollardkJ.SommerlC & van DoornP. (2006). ‘European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy’, European Journal of Neurology, Vol. 13, pp.802-808.10.1111/j.1468-1331.2006.01466.x16879289Search in Google Scholar

Stangel, M., Gold, R., Pittrow, D., Baumann, U., Borte, M., Fasshauer, M., Hensel, M., Huscher, D., Reiser, M & Sommer, C. (2016). ‘Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry’, Therapeutic Advances in Neurological Disorders, Vol. 9, No. 3: pp.165–179.StangelM.GoldR.PittrowD.BaumannU.BorteM.FasshauerM.HenselM.HuscherD.ReiserM & SommerC. (2016). ‘Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry’, Therapeutic Advances in Neurological Disorders, Vol. 9, No. 3: pp.165–179.10.1177/1756285616629869481101127134672Search in Google Scholar

Sutedja, N. (2010). ‘Risk factors for motor neuron diseases, genes, environment and lifestyle’, Utrecht University, Rotterdam, The Netherlands.SutedjaN. (2010). ‘Risk factors for motor neuron diseases, genes, environment and lifestyle’, Utrecht University, Rotterdam, The Netherlands.Search in Google Scholar

Vlam, L., Stam, M., Jager, W., Cats, E., van den Berg, L & van der Pol, W. (2015). ‘Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy’, Journal of Neuroimmunology, Vol. 286, pp.1-4.VlamL.StamM.JagerW.CatsE.van den BergL & van der PolW. (2015). ‘Cytokine profiles in multifocal motor neuropathy and progressive muscular atrophy’, Journal of Neuroimmunology, Vol. 286, pp.1-4.10.1016/j.jneuroim.2015.06.00826298317Search in Google Scholar

Yuki, N., Watanabe, H., Nakajima, T & Spath, P. (2010). ‘IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy’, Journal of Neurology Neurosurgery Psychiatry, Vol. 82, pp.87-91YukiN.WatanabeH.NakajimaT & SpathP. (2010). ‘IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy’, Journal of Neurology Neurosurgery Psychiatry, Vol. 82, pp.87-9110.1136/jnnp.2010.20585620667861Search in Google Scholar